Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Garraway, Levi A

Class:IdPerson:6798868
_displayNameGarraway, Levi A
_timestamp2015-09-21 15:50:29
created[InstanceEdit:6798869] Rothfels, Karen, 2015-09-21
firstnameLevi A
initialLA
surnameGarraway
(author)[LiteratureReference:6799041] A genome-scale RNA interference screen implicates NF1 loss in resistance to RAF inhibition
[LiteratureReference:8850924] Melanoma genome sequencing reveals frequent PREX2 mutations
[LiteratureReference:9647340] Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma
[LiteratureReference:9648790] RNF43 is frequently mutated in colorectal and endometrial cancers
[LiteratureReference:9651920] Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling
[LiteratureReference:9652007] The genetic landscape of clinical resistance to RAF inhibition in metastatic melanoma
[LiteratureReference:9652693] Phenotypic Characterization of a Comprehensive Set of MAPK1/ERK2 Missense Mutants
[LiteratureReference:9657180] A brain-penetrant RAF dimer antagonist for the noncanonical BRAF oncoprotein of pediatric low-grade astrocytomas
[LiteratureReference:9858124] Intronic miR-211 assumes the tumor suppressive function of its host gene in melanoma
[LiteratureReference:9858462] BCL2A1 is a lineage-specific antiapoptotic melanoma oncogene that confers resistance to BRAF inhibition
List all 11 refering instances
[Change default viewing format]
No pathways have been reviewed or authored by Garraway, Levi A (6798868)